Stay updated on Amifampridine in MuSK-MG Clinical Trial
Sign up to get notified when there's something new on the Amifampridine in MuSK-MG Clinical Trial page.

Latest updates to the Amifampridine in MuSK-MG Clinical Trial page
- Check2 days agoChange DetectedThe page gains a glossary toggle and updated metadata, including 'Last Update Submitted that Met QC Criteria' and a new revision tag 'Revision: v3.4.0'. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.2%

- Check9 days agoNo Change Detected
- Check16 days agoChange DetectedRevision: v3.3.4 replaces v3.3.3 as the page revision label. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check37 days agoChange DetectedThe page now presents a single 'Locations' section listing Ohio and Pennsylvania, replacing the separate 'Ohio Locations' and 'Pennsylvania Locations' entries. The 'HHS Vulnerability Disclosure' footer link was removed and the page revision updated to v3.3.3.SummaryDifference0.3%

- Check66 days agoChange DetectedRevision history updated: added v3.3.2 and removed v3.2.0.SummaryDifference0.1%

- Check73 days agoChange DetectedThe government funding/operating status notice at the top of the page has been removed.SummaryDifference0.4%

- Check87 days agoChange DetectedMinor UI and layout updates observed on the Study Details page, with no changes to core content such as the study title, eligibility criteria, or primary outcomes. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.5%

Stay in the know with updates to Amifampridine in MuSK-MG Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Amifampridine in MuSK-MG Clinical Trial page.